These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7517260)

  • 21. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor.
    Schwartzberg LS; Birch R; Hazelton B; Tauer KW; Lee P; Altemose R; George C; Blanco R; Wittlin F; Cohen J
    J Hematother; 1992; 1(4):317-27. PubMed ID: 1285381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma.
    Negrin RS; Kusnierz-Glaz CR; Still BJ; Schriber JR; Chao NJ; Long GD; Hoyle C; Hu WW; Horning SJ; Brown BW
    Blood; 1995 Jun; 85(11):3334-41. PubMed ID: 7538824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood.
    Murray L; Chen B; Galy A; Chen S; Tushinski R; Uchida N; Negrin R; Tricot G; Jagannath S; Vesole D
    Blood; 1995 Jan; 85(2):368-78. PubMed ID: 7529060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maturation of mobilized peripheral blood progenitor cells: preclinical and phase I clinical studies.
    Chang Q; Hanks S; Akard L; Thompson J; Harvey K; English D; Jansen J
    J Hematother; 1995 Aug; 4(4):289-97. PubMed ID: 7489143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of CD34+ cells mobilized to the peripheral blood during the recovery from cyclophosphamide chemotherapy.
    Bender JG; Unverzagt KL; Walker DE; Lee W; Lum L; Van Epps DE; Williams SF; To LB
    Prog Clin Biol Res; 1992; 377():575-82. PubMed ID: 1279727
    [No Abstract]   [Full Text] [Related]  

  • 26. Circulating stem cell collection in lymphoma and myeloma after mobilization with cyclophosphamide and granulocyte colony-stimulating factor for autologous transplantation.
    Cancelas JA; Hernández-Jodra M; Zamora C; Perez-Oteyza J; Brieva JA; Roldan E; Navas G; Garcia-Laraña J; Lopez J; Odriozola J
    Vox Sang; 1994; 67(4):362-7. PubMed ID: 7535498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progenitor cell numbers (CFU-GM, CFU-D, and CFU-Mix) and hemopoietic recovery following autologous marrow transplantation.
    Stewart FM; Kaiser DL; Ishitani KP; Pirsch GW; Niskanen E
    Exp Hematol; 1989 Oct; 17(9):974-80. PubMed ID: 2673831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma.
    Pettengell R; Testa NG; Swindell R; Crowther D; Dexter TM
    Blood; 1993 Oct; 82(7):2239-48. PubMed ID: 7691253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity.
    Fritsch G; Emminger W; Buchinger P; Printz D; Gadner H
    Exp Hematol; 1991 Dec; 19(11):1079-83. PubMed ID: 1721590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro expansion of CD34+ cells mobilized with chemotherapy and G-CSF.
    Teofili L; Iovino MS; Di Mario A; Ortu La Barbera E; Pierelli L; Bussa S; Rumi C; Menichella G; Leone G
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():89-95. PubMed ID: 7516922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of peripheral blood progenitor cells mobilized by cytotoxic chemotherapy and recombinant human granulocyte colony-stimulating factor.
    Haas R; Möhle R; Murea S; Goldschmidt H; Pförsich M; Witt B; Hunstein W
    J Hematother; 1994; 3(4):323-30. PubMed ID: 7537608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-color flow cytometric analysis of CD34-positive peripheral blood stem cells mobilized by recombinant human granulocyte-colony stimulating factor for autotransplantation.
    Inaba T; Shimazaki C; Ashihara E; Ohkawa K; Oku N; Gotoh H; Fujita N; Tsuji H; Nakagawa M
    Prog Clin Biol Res; 1992; 377():561-7. PubMed ID: 1279725
    [No Abstract]   [Full Text] [Related]  

  • 33. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis.
    Pettengell R; Morgenstern GR; Woll PJ; Chang J; Rowlands M; Young R; Radford JA; Scarffe JH; Testa NG; Crowther D
    Blood; 1993 Dec; 82(12):3770-7. PubMed ID: 7505124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product.
    Dreger P; Marquardt P; Haferlach T; Jacobs S; Mülverstedt T; Eckstein V; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N
    Br J Cancer; 1993 Nov; 68(5):950-7. PubMed ID: 7692921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy.
    Venturini M; Del Mastro L; Melioli G; Balleari E; Garrone O; Pasquetti W; Bason C; Ghio R; Bruzzi P; Rosso R
    Cancer; 1994 Oct; 74(8):2300-6. PubMed ID: 7522948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.
    Brugger W; Henschler R; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    Blood; 1994 Sep; 84(5):1421-6. PubMed ID: 7520769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma.
    Schiller G; Vescio R; Freytes C; Spitzer G; Sahebi F; Lee M; Wu CH; Cao J; Lee JC; Hong CH
    Blood; 1995 Jul; 86(1):390-7. PubMed ID: 7540888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy support.
    Benjamin RJ; Linsley L; Axelrod JD; Churchill WH; Sieff C; Shulman LN; Elias A; Ayash L; Malachowski ME; Uhl L
    Transfusion; 1995 Oct; 35(10):837-44. PubMed ID: 7570914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Autografts of blood cells at various stages].
    Castaigne S; Dal Cortivo L; Leverger G; Miclea JM; Lepage E; Benbunan M; Gerota J; Degos L; Boiron M
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):69-73. PubMed ID: 2898752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients.
    Siena S; Bregni M; Brando B; Belli N; Ravagnani F; Gandola L; Stern AC; Lansdorp PM; Bonadonna G; Gianni AM
    Blood; 1991 Jan; 77(2):400-9. PubMed ID: 1702334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.